In our results, SX-H intervention led to upregulation of PPARα in NAFLD rats, possibly through the β-oxidation pathway to increase fatty acid decomposition and reduce lipid accumulation. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.